Issues related to availability of medicines have been in the headlines in all over Europe.
In future, the package leaflet may be an electronic smart document which reminds you to take your pill or to renew a prescription.
Many pharmaceutical companies have not yet submitted the necessary applications, and the deadline is already around the corner.
From the perspective of a person working in the pharmaceutical industry, the benefit/risk relationship of clear language is solely positive as benefits are numerous yet there are no adverse effects at all.
Multilingual Nordic packages are an important option for making medicines available in as many countries in the Nordic region as possible.
Last autumn, DRA was invited to participate in a pilot project concerned with real-life testing of the Pharmaceuticals Pricing Board’s electronic services.